The vaccine manufacturers are once again the focus of investors. On the other hand, the fruit multinational Dole and the weapons manufacturer Smith & Wesson are on the losing side.

new York The US stock exchanges at the end of the week supported the hope of a sustained flood of money from the Fed. After a disappointing job build-up in November, equity investors were betting on the Fed turning away from its crisis mode less quickly.

At first it appeared that prices were not going to slide significantly despite weak labor market data. However, the Dow Jones index later traded 0.4 percent lower at 34,494 points. Technology stocks led the S&P 500 declines while the Nasdaq 100 fell more sharply

The broader S&P 500 was down 1.2 percent to 4523 meters. The index of the technology exchange Nasdaq even lost 2.5 percent to 15,595 points. One of the most important reasons for today’s stock market trend is the current US job data.

According to the latest survey, the number of people employed outside the agricultural sector rose by just 210,000 this month. Experts had predicted the creation of 550,000 new jobs outside of US agriculture in November. This is the lowest job growth in the calendar year to date.

But what makes it difficult to interpret the numbers: The unemployment rate has fallen significantly, the minus of 0.4 percent does not match the low number of newly created jobs. The unemployment rate in the US has thus reached a new post-pandemic low.

Fed is unlikely to accelerate the pace of lowering bond purchases

The labor market data are considered to be an important yardstick for US monetary policy. The question is at what pace US monetary authorities will further reduce their loose monetary policy.

For Thomas Altmann from the investment house QC Partners, this labor market report is likely to “send the US Federal Reserve into waiting and observation mode for the time being”. The Fed will probably stick to its current pace in lowering bond purchases (“tapering”), but the acceleration that is currently being discussed is unlikely to materialize.

Thomas Hayes, executive member of asset manager Great Hill Capital in New York, also classifies the event: “An obvious disappointment and the stock markets are rising because investors now expect that the Fed cannot be so fast.”

In mid-November, the Federal Reserve began scaling back its asset purchases by $ 15 billion a month. Some central bankers had recently pleaded for more speed. The end of the so-called tapering is a prerequisite for a turnaround in interest rates.

Look at the individual values

Dole: Investors are turning away after the latest business figures from Frucht-Multi Dole. The shares of the supplier of fruit and vegetables fall by up to seven percent. The brand, which is known for its canned pineapple, among other things, achieved sales of $ 2.32 billion less than hoped for in the third quarter. Revenues were also lower than expected, which the company attributed to supply chain problems, among other things. In addition, problems in the personnel area had a negative impact on vegetable production.

Biontech, Moderna and Novavax: Once again, the vaccine manufacturer’s stocks are the focus of investors. A recently published study from Great Britain, in which the mRNA vaccines performed best in terms of effectiveness, should influence the price development. For the Biontech shares listed on the US stock exchange, it went up by almost three percent.

Didi: Just five months after its debut, Chinese Uber rival Didi, under heavy pressure from China’s regulators, announced plans to withdraw from the New York Stock Exchange. The delisting in the USA will begin immediately. The Uber competitor took to the floor in New York despite the request to postpone the plans and, according to insiders, has been in the sights of the Chinese supervisory authorities since then. According to insiders, Didi wants to be listed on the Hong Kong stock exchange within three months. At the start of the stock exchange, Didi shares continued to decline. The trend had already started in pre-market trading.

Smith & Wesson: After a decline in sales, many investors threw the shares of the weapons manufacturer Smith & Wesson from the depots. The papers lose around nineteen percent on Wall Street. In the quarter, the group made 7.3 percent less sales.

More: These are the rise candidates for MDax and SDax – What investors should know about stocks